Instruments

Name Stock exchange Average volume Price Type
WAL-MART DE MÉXICO, S.A.B. DE C.V. WALMEX *

Mexican S.E. +3 Other

19,004,563 66.78 MXN Stock Wal-Mart de México, S.A.B. de C.V. Stock
WAL-MART DE MÉXICO, S.A.B. DE C.V. 4GNB

Deutsche Boerse AG

455 3.64 EUR Stock Wal-Mart de México, S.A.B. de C.V.
WAL-MART DE MÉXICO, S.A.B. DE C.V. 4GNB

Börse Stuttgart

- 3.56 EUR Stock Wal-Mart de México, S.A.B. de C.V.
WAL-MART DE MÉXICO, S.A.B. DE C.V. WMMVF

OTC Markets

5,600 3.923 USD Stock Wal-Mart de México, S.A.B. de C.V.
WAL-MART DE MÉXICO, S.A.B. DE C.V. WMMVY

OTC Markets

34,171 40.11 USD Stock Wal-Mart de México, S.A.B. de C.V. Stock
AMÉRICA MÓVIL, S.A.B. DE C.V. AMX

Buenos Aires S.E. +1 Other

76 23,580 ARS Stock América Móvil, S.A.B. de C.V. Stock
AMÉRICA MÓVIL, S.A.B. DE C.V. AMXD

Buenos Aires S.E.

9 19.5 USD Stock América Móvil, S.A.B. de C.V.
AMÉRICA MÓVIL, S.A.B. DE C.V. AMX B

Mexican S.E. +4 Other

74,529,297 16.36 MXN Stock América Móvil, S.A.B. de C.V. Stock
AMÉRICA MÓVIL, S.A.B. DE C.V. XAMXB

BME

- 0.91 EUR Stock América Móvil, S.A.B. de C.V.
AMÉRICA MÓVIL, S.A.B. DE C.V. MV91

Deutsche Boerse AG

- 0.86 EUR Stock América Móvil, S.A.B. de C.V.
AMÉRICA MÓVIL, S.A.B. DE C.V. MV91

Börse Stuttgart

- 0.835 EUR Stock América Móvil, S.A.B. de C.V.
AMÉRICA MÓVIL, S.A.B. DE C.V. AMXOF

OTC Markets

3,462 1.05 USD Stock América Móvil, S.A.B. de C.V.
AMÉRICA MÓVIL, S.A.B. DE C.V. AMX

Nyse +7 Other

1,627,244 19.71 USD Stock América Móvil, S.A.B. de C.V. Stock
AMÉRICA MÓVIL, S.A.B. DE C.V. AMX

Nyse

1,655,962 17.6 USD Stock América Móvil, S.A.B. de C.V.
AMÉRICA MÓVIL, S.A.B. DE C.V. MV90

Deutsche Boerse AG

- 17.7 EUR Stock América Móvil, S.A.B. de C.V.
AMÉRICA MÓVIL, S.A.B. DE C.V. MV9L

Börse Stuttgart

- 19.7 EUR Stock América Móvil, S.A.B. de C.V.
AMÉRICA MÓVIL, S.A.B. DE C.V. MV9L

BOERSE MUENCHEN

- 19.7 EUR Stock América Móvil, S.A.B. de C.V.
AMÉRICA MÓVIL, S.A.B. DE C.V. MV9L

Berne S.E.

- - CHF Stock América Móvil, S.A.B. de C.V.
AMÉRICA MÓVIL, S.A.B. DE C.V. MV90

BOERSE MUENCHEN

- 18.3 EUR Stock América Móvil, S.A.B. de C.V.
AMÉRICA MÓVIL, S.A.B. DE C.V. MV90

Börse Stuttgart

- 17.7 EUR Stock América Móvil, S.A.B. de C.V.
AÉROPORTS DE PARIS ADP

Euronext Paris +7 Other

71,809 127.6 EUR Stock Aéroports de Paris Stock
AÉROPORTS DE PARIS W7L

Deutsche Boerse AG

- 127 EUR Stock Aéroports de Paris
AÉROPORTS DE PARIS 0NP8

London S.E.

- 127.3 EUR Stock Aéroports de Paris
AEROPORTS DE PARIS SA ADP N

Mexican S.E.

- 2,541 MXN Stock Aeroports de Paris SA
AÉROPORTS DE PARIS W7L

Börse Stuttgart

- 126.9 EUR Stock Aéroports de Paris
AÉROPORTS DE PARIS W7L

BOERSE MUENCHEN

- 127.3 EUR Stock Aéroports de Paris
AÉROPORTS DE PARIS AEOXF

OTC Markets

264 134.4 USD Stock Aéroports de Paris
AEROPORTS DE PARIS SA ADPA

Wiener Boerse

- 127.6 EUR Stock Aeroports de Paris SA
BANCO DE CHILE CHILE

Santiago S.E. +1 Other

102,569,009 108.3 CLP Stock Banco de Chile Stock
BANCO DE CHILE CHILECO

Bolsa De Valores De Colombia

- 464 COP Stock Banco de Chile
BANCO DE CHILE BCH

Nyse +2 Other

395,945 24.28 USD Stock Banco de Chile Stock
BANCO DE CHILE G4RA

Deutsche Boerse AG

- 22.2 EUR Stock Banco de Chile
BANCO DE CHILE G4RA

Börse Stuttgart

- 23.2 EUR Stock Banco de Chile
DUPONT DE NEMOURS, INC. DD

Nyse +10 Other

2,460,333 78.55 USD Stock DuPont de Nemours, Inc. Stock
DUPONT DE NEMOURS, INC. DDPN

Wiener Boerse

- 73.48 EUR Stock DuPont de Nemours, Inc.
DUPONT DE NEMOURS, INC. 6D81

Deutsche Boerse AG

- 73.05 EUR Stock DuPont de Nemours, Inc.
DUPONT DE NEMOURS, INC. 0A6B

London S.E.

116 79.63 USD Stock DuPont de Nemours, Inc.
DUPONT DE NEMOURS, INC. 6D81

Börse Stuttgart

- 73.03 EUR Stock DuPont de Nemours, Inc.
DUPONT DE NEMOURS, INC. DD *

Mexican S.E.

1,477 1,320 MXN Stock DuPont de Nemours, Inc.
DUPONT DE NEMOURS, INC. 6D81

Frankfurt

- 72.43 EUR Stock DuPont de Nemours, Inc.
DUPONT DE NEMOURS DOWCP

Euronext Paris

- - EUR Stock DuPont de Nemours
DUPONT DE NEMOURS, INC. 6D81

BOERSE MUENCHEN

121 72.42 EUR Stock DuPont de Nemours, Inc.
DUPONT DE NEMOURS, INC. 4DD

Borsa Italiana

- 72.6 EUR Stock DuPont de Nemours, Inc.
DUPONT DE NEMOURS, INC. 6D81

Berne S.E.

216 68.49 CHF Stock DuPont de Nemours, Inc.
EL PUERTO DE LIVERPOOL, S.A.B. DE C.V. LIVEPOL 1

Mexican S.E.

831 152 MXN Stock El Puerto de Liverpool, S.A.B. de C.V. Stock

News (22)

Abivax reports 2023 financial results and operational update EQ
Transcript : ABIVAX Société Anonyme - Special Call
Abivax reports 2022 financial results and operations update EQ
Transcript : CinCor Pharma, Inc. - Special Call
Transcript : CinCor Pharma, Inc. - Special Call
Ipsen : Delivers Strong 2016 Results and Expects Further Sales Growth and Margin Enhancement for 2017 BU
Transcript : Ipsen S.A., H1 2016 Earnings Call, Jul 28, 2016
Exelixis and Its Partner Ipsen Announce Positive Overall Survival Results from Subgroup Analyses of Phase 3 Trial of CABOMETYX™ (cabozantinib) Tablets in Advanced Renal Cell Carcinoma at 2016 ASCO Annual Meeting BU
Exelixis : and Its Partner Ipsen Announce Positive Overall Survival Results from Subgroup Analyses of Phase 3 Trial of CABOMETYX™ (cabozantinib) Tablets in Advanced Renal Cell Carcinoma at 2016 ASCO Annual Meeting BU
Exelixis : and Its Partner Ipsen Announce Phase 3 Trial Results of CABOMETYX™ (Cabozantinib) Tablets Demonstrating Significant Overall Survival Benefit for Previously Treated Patients with Advanced Renal Cell Carcinoma Presented at ASCO BU
Exelixis and its partner Ipsen announce phase 3 trial results of CABOMETYX™ (cabozantinib) tablets demonstrating significant overall survival benefit for previously treated patients with advanced renal cell carcinoma presented at ASCO BU
Exelixis and Ipsen Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Regions Outside the United States, Canada and Japan BU
Exelixis : and Ipsen Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Regions Outside the United States, Canada and Japan BU
Transcript : Ipsen S.A. - Analyst/Investor Day
Transcript : Ipsen S.A., 2014 Earnings Call, Mar 03, 2015
Ipsen :’s 2014 Results and 2015 Financial Objectives BU
Ipsen: Sales in the Fourth Quarter and Full Year 2014 BU
Ipsen :’s Somatuline® Depot® is the First Therapy Approved by the FDA in the United States for the Treatment of Patients with Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumors BU
Ipsen : Somatuline® Depot® is the first therapy approved by the FDA in the United States for the treatment of patients with locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors PU
Ipsen: sales in the 3rd quarter and first nine months of 2014 BU
IPSEN : Detailed results of the phase III CLARINET study at the European Cancer Congress 2013 on 28 September 2013 PU
Goldman Sachs Group : Goldman Sachs Announces New Members of the Partnership Pool and New Managing Directors BU

Companies (2022)

S&P GLOBAL, INC. 138 B $
Logo S&P Global, Inc.

S&P Global, Inc. is one of the world's leading companies specializing in financial information services for investors, corporations, governments, financial institutions, investment managers and advisors. Net sales (including intragroup) break down by acti ...

BANK OF MONTREAL 69 024 M $
Logo Bank of Montreal

Bank of Montreal (BMO) is a Canada-based company, which offers a wide range of personal banking services. The Company is engaged in providing a broad range of personal and commercial banking, wealth management, global markets and investment banking produc ...

CHUBB LIMITED 111 B $
Logo Chubb Limited

Chubb Limited is a Switzerland-based holding company. The Company, through its subsidiaries, provides a range of insurance and reinsurance products and services to clients around the world. Its segments include North America Commercial property and casual ...

LVMH 417 B $
Logo LVMH

LVMH Moët Hennessy Louis Vuitton SE is the world leader in luxury products. Net sales break down by family of products as follows: - fashion and leather items (48.9%): brands such as Louis Vuitton, Kenzo, Celine, Fendi, Marc Jacobs, Givenchy, etc.; - wa ...

ALTRIA GROUP, INC. 79 578 M $
Logo Altria Group, Inc.

Altria Group, Inc. is a holding company organized around three sectors of activity: - manufacturing of tobacco products (88.9% of net sales): cigarettes (brands Marlboro, L&M, Philip Morris, Chesterfield, etc.), cigars (Black & Mild), and pipe tobacco; ...

AUTOZONE, INC. 48 809 M $
Logo AutoZone, Inc.

AutoZone, Inc. specializes in distributing automotive spare parts and accessories. The group offers compressors, batteries, carburetors, clutches, des rotors, des motors, fuel pumps, etc. Net sales break down by activity as follows: - retail and professi ...

WAL-MART DE MÉXICO, S.A.B. DE C.V. 70 259 M $
Logo Wal-Mart de México, S.A.B. de C.V.

Wal Mart de Mexico SAB de CV is a Mexico-based company engaged in operating self-service stores. The Company's segments include Mexico and Central America. In Mexico, the Company operates through Self-service, which includes the operation of discount stor ...

PHILIP MORRIS INTERNATIONAL, INC. 156 B $
Logo Philip Morris International, Inc.

Philip Morris International, Inc. is one of the world leading producers of cigarettes and tobacco products. In 2023, the group sold 612.9 billion cigarettes (under the brand names Marlboro, Parliament, Chesterfield, L&M, Bond Street, Philip Morris, Next, ...

FAST RETAILING CO., LTD. 81 428 M $
Logo Fast Retailing Co., Ltd.

Fast Retailing Co., Ltd. specializes in the distribution of clothes for men, women and children. At the end of August 2023, the marketing of the products is ensured through a network of 3,578 stores broken down by name mainly between Uniqlo (2,434), G.U. ...

ARM HOLDINGS PLC 119 B $
Logo Arm Holdings plc

Arm Holdings plc is a semiconductor intellectual property (IP) company. The Company develops and licenses IP for various devices worldwide, and it provides development tools that accelerate product development, from sensors to smartphones to servers. Its ...


1234Next

Insiders

Picture Marc M. P. de Garidel
Marc M. P. de Garidel

Marc M. P. de Garidel is a French businessperson who founded Leem and who has been at the head of 11 different companies. He occupies the position of Non-Executive Chairman for Ipsen SA, Chairman at Ipsen Pharma SAS (a subsidiary of Ipsen SA), Chairman of G5, Chairman at Vectorlab GmbH and Chief Executive Officer & Director at AZTherapies, Inc. He is also on the board of European Federation of Pharmaceutical Industries & Assns, The Innovative Medicines Initiative and Société des Membres de la Légion d'Honneur and Professor at ESSEC Business School and Professor at ESCP Europe Campus Paris. In his past career he held the position of Non-Executive Chairman of PROMETHERA Biosciences SA, Chairman & Vice President at European Biopharmaceutical Enterprises, Finance Director for Eli Lilly & Co., Vice President-International at Amgen, Inc., Chairman for Suraypharm SAS, Chairman & Chief Executive Officer for Ipsen Pharma SAS, Chief Executive Officer & Director at Corvidia Therapeutics, Inc. and President at Leem. He received an undergraduate degree from Ecole Spéciale des Travaux Publics, a graduate degree from Thunderbird School of Global Management and an MBA from Harvard Business School.


Picture W. P. M. de Silva
W. P. M. de Silva

Ms. W.
P.
M.
de Silva
is Accountant at Chilaw Finance Plc.


Picture M. P. P. Rousset
M. P. P. Rousset

M.
P.
P.
Rousset
was a Non-Executive Director at Ciel Ltd.


Picture P. P. M. Nielen
P. P. M. Nielen

P.
P.
M.
Nielen
is the founder of Nielen Schuman BV.
Currently, he is the Chairman of Happy Watoto Foundation and a Member-Supervisory Board at PB Holding NV.
Previously, he worked as a Partner at Scheybeeck Investments BV from 2015 to 2020.
He completed his undergraduate degree from Vrije Universiteit Amsterdam.


No results for this search

  1. Stock Market
  2. Advanced search
  3. Marc M. P. de Garidel